The FDA is asking Novavax for a non-mandatory postmarketing commitment to produce additional clinical data for its investigational COVID-19 vaccine.
After Missed Decision Deadline, Novavax Says COVID-19 Shot ‘Approvable’ Read More »
With a new raise provided by Flagship Pioneering, the new company is aiming to find “the silent window” before disease symptoms set in.
Etiome Steps Out of Stealth with $50M to Address Disease At The ‘Silent Stage’ Read More »
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses how collaboration and investment shape the the future of women’s health with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
Economic Challenges, Strategic Investments: Reshaping the Women’s Health Landscape Read More »
Roche’s exposure to the tariffs is mostly limited to four medicines, three of which it already produces in the U.S., according to CEO Thomas Schinecker, who declined to reveal what these assets are.
Roche in ‘Very, Very Good Position’ to Weather Trump Tariffs, But M&A May Suffer Read More »
Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca executive and Eli Lilly and Novo Nordisk spokespeople discuss potential job and skill-building opportunities and where manufacturing might head in the future.
Massive Investment in US Manufacturing Triggers Wave of Career Opportunities Read More »
Where thousands of former Health and Human Services employees will work next is unknown, but biopharma companies likely aren’t the main destination. Two biopharma executives discuss potential landing spots.
Guessing Game: Former HHS Workers’ Next Stops Unclear Read More »
Proquad is rarely a newsmaker from Merck’s earnings, but this time around, the U.S. has had a series of measles outbreaks. Sales of the vaccine were $539 million for the quarter, a 5% decline from the same period in 2024.
Sales Of Merck’s 4-Way Measles Vaccine Take Hit as US Dips Into Stockpile Read More »
El cáncer de páncreas es uno de los más agresivos y con una de las tasas de supervivencia más bajas, de solo el 10% al cabo de cinco años. Uno de los factores que contribuyen a esta agresividad es su microambiente tumoral, conocido como estroma, que representa la m …
Identifican una de las claves de la alta agresividad del cáncer de páncreas Read More »
Al igual que un piloto puede practicar maniobras en un simulador de vuelo, los científicos pronto podrán realizar experimentos con una simulación realista de un cerebro. Unos investigadores han utilizado un modelo de inteligencia artificial para construir un “gemelo digita …
Unos científicos trabajan en un nuevo tipo de materiales adhesivos aptos para tejidos vivos. Estos materiales adhesivos se basan en una combinación de hidrogeles con polímeros que se comportan como pegamentos y permiten conectar, de manera segura y duradera, tejidos humanos a di …
Nueva clase de bioadhesivos para implantes médicos permanentes Read More »
